Know your market.
Know your competitors, industry, value, buyers and comparables.
NeuraCap evaluates companies the way an investment banker does. Filings, estimates, comparables and transaction records, read continuously and written up as institutional coverage.
Every industry report published free. No email required.
The bottom line
The operating record keeps compounding while the trading multiple keeps contracting.
- MethodsReference range of $422.32 – $624.04 across the applied methods
- Operating11.4% revenue growth at a 46.9% EBITDA margin, against peer averages of 19.7% and 31.8%
- FilingsThe $1.9bn Semrush purchase set out in the 10-K closed on schedule in April 2026
Valuation methods applied
Illustrative valuation perspectives — not an opinion of value, not a fairness opinion, not a price target.
- Consensus market estimates
- M&A deals
- Public comparables
- SEC data
- Earnings transcripts
- Press releases
- Broker research
Evidence
Every figure confirmed against two independent sources.
What we publish
Three formats, one method behind them.
Company Reports
One company valued the way a banker would value it: methods, peer benchmarks, precedent transactions and the strategic options that follow. Monthly for public companies, on demand for private.
See a company report →Bi-weekly across 30+ sectorsSector Coverage
What moved, what companies announced, and what changed in M&A, every two weeks. Deeper sector reports set out the landscape, the valuation spread and the transaction record.
Browse sectors →EngagementAdvisory
When the analysis needs a person behind it. Custom work built on the same evidence base, scoped to the decision in front of you.
Talk to advisory →The platform
Ask your company anything.
Compare yourself against peers, test a multiple, understand what moved the sector. Answers come back with the figures and the sources behind them, and every report downloads as a document you can send to a board, a lender or a client.
See the Financial Assistant →How does our EBITDA margin compare to the peer set?
Your 46.9% EBITDA margin sits well above the 31.8% peer average, while revenue growth of 11.4% sits below their 19.7%. The market is paying for the growth, not the margin.
7 comparables · consensus CY2026 · sources attached
Always running
You never have to ask. NeuraCap is already working.
No prompt, no query, no blank search bar. Coverage runs continuously against your sector and reaches out the moment something matters.
- It watches
- Markets, filings, public comps, transactions and earnings — around the clock.
- It forms a view
- Insights built around decades of institutional judgement, applied the same way every time.
- It reaches out
- Institutional insight delivered through software and AI, the moment something matters.
- Scanning SEC EDGAR filings04:12
- Reading earnings transcripts07:38
- Repricing the comparable set11:05
- Coverage published16:20
Delivered without a single request from you.
Latest coverage
Read it before you talk to us.
Coverage is being published. Browse the reports library for everything currently available.
Get your custom-built strategic insights report today.
Public or private, any sector. Tell us the company and what you need to understand.